TABLE 5.
In vitro drug release kinetics of the optimized nanoformulation.
| Formulation | First-order (R2) | Zero-order (R2) | Hixson–Crowell (R2) | Higuchi (R2) | Korsmeyer–Peppas (R2) | (n*) |
|---|---|---|---|---|---|---|
| Polox50 | 0.6714 | 0.936 | 0.9636 | 0.9947 | 0.9923 | 0.61 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.